Skip to main content
SpringerLink
Log in

Survival Outcomes and Prognostic Factors of Surgical Therapy for All Potentially Resectable Intrahepatic Cholangiocarcinoma: a Large Single-Center Cohort Study

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

Surgical resection is currently indicated for all potentially resectable intrahepatic cholangiocarcinoma (ICC), but the survival outcomes and the prognostic factors have not been well-documented due to its rarity. This study aims to assess these in a large, consecutive series of patients with ICC treated surgically.

Methods

A retrospective study was conducted on 1,333 ICC patients undergoing surgery between January 2007 and December 2011. Surgical results and survival were evaluated and compared among different subgroups of patients. Univariate and multivariate analyses were performed to identify prognostic factors.

Results

R0, R1, R2 resection and exploratory laparotomy were obtained in 34.8, 44.9, 16.4, and 3.9 % of the patients, respectively. The overall 1-, 3-, and 5-year survival rates for the entire cohort were 58.2, 25.2, and 17.0 %, respectively, with corresponding rates of 79.1, 42.6, and 28.7 % for patients with R0 resection; 60.5, 20.1, and 13.9 % for patients with R1 resection; 20.5, 7.4, and 0 % for patients with R2 resection; and 3.8, 0, and 0 % for patients with an exploratory laparotomy. Independent factors for poor survival included positive resection margin, lymph node metastasis, multiple tumors, vascular invasion, and elevated CA19-9 and/or CEA, whereas hepatitis B virus infection and cirrhosis were independently favorable prognosis indicators.

Conclusions

R0 resection offers the best possibility of long-term survival, but the chance of a R0 resection is low when surgery is performed for potential resectable ICC. Further randomized trials are warranted to refine indications for surgery in the management of ICC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Patel T. Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol 2011;8:189–200.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005;366:1303–14.

    Article  PubMed  Google Scholar 

  3. Poultsides GA, Zhu AX, Choti MA, Pawlik TM. Intrahepatic cholangiocarcinoma. Surg Clin North Am 2010;90:817–37.

    Article  PubMed  Google Scholar 

  4. Sempoux C, Jibara G, Ward S, Fan C, Qin L, Roayaie S et al. Intrahepatic Cholangiocarcinoma: New Insights in Pathology. Seminars in Liver Disease 2011;31:049–60.

    Article  Google Scholar 

  5. Lang H, Sotiropoulos GC, Fruhauf NR, Domland M, Paul A, Kind EM et al. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg 2005;241:134–43.

    PubMed  Google Scholar 

  6. Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 2008;248:84–96.

    Article  PubMed  Google Scholar 

  7. Tan JC, Coburn NG, Baxter NN, Kiss A, Law CH. Surgical management of intrahepatic cholangiocarcinoma--a population-based study. Ann Surg Oncol 2008;15:600–8.

    Article  PubMed  Google Scholar 

  8. Jonas S, Thelen A, Benckert C, Biskup W, Neumann U, Rudolph B et al. Extended liver resection for intrahepatic cholangiocarcinoma: A comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg 2009;249:303–9.

    Article  PubMed  Google Scholar 

  9. Roayaie S, Guarrera JV, Ye MQ, Thung SN, Emre S, Fishbein TM et al. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg 1998;187:365–72.

    Article  CAS  PubMed  Google Scholar 

  10. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000;69:1633–7.

    Article  CAS  PubMed  Google Scholar 

  11. Weimann A, Varnholt H, Schlitt HJ, Lang H, Flemming P, Hustedt C et al. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg 2000;87:1182–7.

    Article  CAS  PubMed  Google Scholar 

  12. DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007;245:755–62.

    Article  PubMed  Google Scholar 

  13. Farges O, Fuks D, Boleslawski E, Le Treut YP, Castaing D, Laurent A et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg 2011;254:824–9.

    Article  PubMed  Google Scholar 

  14. Uenishi T, Yamazaki O, Yamamoto T, Hirohashi K, Tanaka H, Tanaka S et al. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2005;12:479–83.

    Article  PubMed  Google Scholar 

  15. Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases. J Surg Oncol 2007;96:160–5.

    Article  PubMed  Google Scholar 

  16. Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM et al. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery 2008;143:366–74.

    Article  PubMed  Google Scholar 

  17. Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 2008;15:2787–94.

    Article  PubMed  Google Scholar 

  18. Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S et al. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Ann Surg Oncol 2010;17:1816–22.

    Article  PubMed  Google Scholar 

  19. de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011;29:3140–5.

    Article  PubMed  Google Scholar 

  20. Uchiyama K, Yamamoto M, Yamaue H, Ariizumi S, Aoki T, Kokudo N et al. Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2011;18:443–52.

    Article  PubMed  Google Scholar 

  21. Li YY, Li H, Lv P, Liu G, Li XR, Tian BN et al. Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment. J Gastrointest Surg 2011;15:608–13.

    Article  PubMed  Google Scholar 

  22. Nanashima A, Sumida Y, Abo T, Nagasaki T, Takeshita H, Fukuoka H et al. Patient outcome and prognostic factors in intrahepatic cholangiocarcinoma after hepatectomy. Hepatogastroenterology. 2007;54(80):2337–42.

    PubMed  Google Scholar 

  23. Jan YY, Yeh CN, Yeh TS, Chen TC. Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol. 2005;11(12):1779–84.

    PubMed  Google Scholar 

  24. Nathan H, Pawlik TM, Wolfgang CL, Choti MA, Cameron JL, Schulick RD. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg 2007;11:1488–96.

    Article  PubMed  Google Scholar 

  25. Dhanasekaran R, Hemming AW, Zendejas I, Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncol Rep. 2013;29(4):1259–67.

    CAS  PubMed  Google Scholar 

  26. Wang Y, Li J, Xia Y, Gong R, Wang K, Yan Z et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 2013;31:1188–95.

    Article  PubMed  Google Scholar 

  27. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004;40:472–7.

    Article  PubMed  Google Scholar 

  28. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471–4.

    Article  PubMed  Google Scholar 

  29. Nathan H, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 2010;26:269–73.

    Article  CAS  PubMed  Google Scholar 

  30. The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan. Jpn J Surg 1989; 19:98–129.

    Google Scholar 

  31. Zhou XD, Tang ZY, Fan J, Zhou J, Wu ZQ, Qin LX et al. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2009;135:1073–80.

    Article  PubMed  Google Scholar 

  32. Tamandl D, Kaczirek K, Gruenberger B, Koelblinger C, Maresch J, Jakesz R et al. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg 2009;96:919–25.

    Article  CAS  PubMed  Google Scholar 

  33. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002;89:1525–31.

    Article  CAS  PubMed  Google Scholar 

  34. Sotiropoulos GC, Bockhorn M, Sgourakis G, Brokalaki EI, Molmenti EP, Neuhäuser M et al. R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis. Dig Dis Sci. 2009;54(4):887–94.

    Article  PubMed  Google Scholar 

  35. Zhou HB, Wang H, Li YQ, Li SX, Zhou DX, Tu QQ et al. Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection. World J Gastroenterol 2011;17:1292–1303.

    Article  PubMed  Google Scholar 

  36. Puhalla H, Schuell B, Pokorny H, Kornek GV, Scheithauer W, Gruenberger T. Treatment and outcome of intrahepatic cholangiocellular carcinoma. Am J Surg 2005;189:173–7.

    Article  PubMed  Google Scholar 

  37. Nakagawa T, Kamiyama T, Kurauchi N, Matsushita M, Nakanishi K, Kamachi H et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 2005;29:728–33.

    Article  PubMed  Google Scholar 

  38. Paik KY, Jung JC, Heo JS, Choi SH, Choi DW, Kim YI. What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol 2008;23:766–70.

    Article  PubMed  Google Scholar 

  39. Miwa S, Miyagawa S, Kobayashi A, Akahane Y, Nakata T, Mihara M et al. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 2006;41:893–900.

    Article  CAS  PubMed  Google Scholar 

  40. Lang H, Sotiropoulos GC, Sgourakis G, Schmitz KJ, Paul A, Hilgard P et al. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 2009;208:218–28.

    Article  PubMed  Google Scholar 

  41. Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009;16:14–22.

    Article  PubMed  Google Scholar 

  42. Morimoto Y, Tanaka Y, Ito T, Nakahara M, Nakaba H, Nishida T et al. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2003;10:432–40.

    Article  PubMed  Google Scholar 

  43. Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T et al. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 2001;92:2374–83.

    Article  CAS  PubMed  Google Scholar 

  44. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353–7.

    Article  CAS  PubMed  Google Scholar 

  45. Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, D’Angelica M et al. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg. 2006;244(2):260–4.

    Article  PubMed  Google Scholar 

  46. Shimada M, Yamashita Y, Aishima S, Shirabe K, Takenaka K, Sugimachi K. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 2001;88:1463–6.

    Article  CAS  PubMed  Google Scholar 

  47. Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O, Shuto T et al. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma. Hepatogastroenterology 2003;50:1069–72.

    PubMed  Google Scholar 

  48. Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 2000;127:498–505.

    Article  CAS  PubMed  Google Scholar 

  49. Rana A, Hong JC. Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 2012;28:258–65.

    Article  CAS  PubMed  Google Scholar 

  50. Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL et al. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients. Cancer J 2006;12:113-22.

    PubMed  Google Scholar 

Download references

Conflict of interest

There is no potential conflict of interest for the individual authors, study participants, or any company.

Funding

We have no sources of funding for research and/or publication of this study.

Author information

Authors and Affiliations

  1. Second Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 225 Changhai Road, Shanghai, 200438, People’s Republic of China

    Xianwu Luo, Lei Yuan, Yi Wang, Ruiliang Ge, Yanfu Sun & Gongtian Wei

Authors
  1. Xianwu Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lei Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruiliang Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yanfu Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gongtian Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yi Wang.

Additional information

Xian-wu Luo and Lei Yuan contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luo, X., Yuan, L., Wang, Y. et al. Survival Outcomes and Prognostic Factors of Surgical Therapy for All Potentially Resectable Intrahepatic Cholangiocarcinoma: a Large Single-Center Cohort Study. J Gastrointest Surg 18, 562–572 (2014). https://doi.org/10.1007/s11605-013-2447-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-013-2447-3

Keywords

Search

Navigation